National Health Investors, Inc. (NYSE:NHI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. The firm currently has a $86.00 target price on the real estate investment trust’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 12.18% from the company’s previous close.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
A number of other research firms have also weighed in on NHI. Stifel Nicolaus reissued a “buy” rating and issued a $82.00 target price on shares of National Health Investors in a research note on Wednesday, October 4th. Capital One Financial Corporation assumed coverage on National Health Investors in a research note on Monday, October 23rd. They set an “equal weight” rating on the stock. BMO Capital Markets reaffirmed a “hold” rating and issued a $80.00 target price on shares of National Health Investors in a report on Wednesday, October 18th. SunTrust Banks, Inc. started coverage on National Health Investors in a research note on Tuesday, October 10th. They issued a “hold” rating and a $80.00 price target for the company. Finally, Mizuho reiterated a “hold” rating and issued a $82.00 price target on shares of National Health Investors in a research report on Wednesday, October 4th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $80.14.
National Health Investors (NYSE:NHI) traded up $0.23 during midday trading on Friday, reaching $76.66. The company had a trading volume of 223,200 shares, compared to its average volume of 192,348. National Health Investors has a fifty-two week low of $67.33 and a fifty-two week high of $81.21. The firm has a market capitalization of $3,183.84, a PE ratio of 14.71, a P/E/G ratio of 3.79 and a beta of 0.58. The company has a quick ratio of 12.45, a current ratio of 12.72 and a debt-to-equity ratio of 0.84.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). The firm had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a net margin of 59.70% and a return on equity of 12.74%. The company’s revenue was up 14.1% on a year-over-year basis. During the same period last year, the business posted $1.22 EPS. sell-side analysts predict that National Health Investors will post 5.25 earnings per share for the current year.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 5.19% of the stock is currently owned by company insiders.
Several large investors have recently modified their holdings of NHI. Schwab Charles Investment Management Inc. lifted its stake in shares of National Health Investors by 9.7% in the first quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock valued at $11,716,000 after purchasing an additional 14,297 shares during the period. BlackRock Inc. raised its position in shares of National Health Investors by 6,473.4% in the first quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock valued at $241,753,000 after buying an additional 3,277,930 shares during the last quarter. Prudential Financial Inc. raised its position in shares of National Health Investors by 137.4% in the second quarter. Prudential Financial Inc. now owns 13,683 shares of the real estate investment trust’s stock valued at $1,084,000 after buying an additional 7,920 shares during the last quarter. Tocqueville Asset Management L.P. raised its position in shares of National Health Investors by 2.3% in the second quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock valued at $348,000 after buying an additional 100 shares during the last quarter. Finally, Good Life Advisors LLC acquired a new position in shares of National Health Investors in the second quarter valued at approximately $282,000. 70.13% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.